Indefinite Delivery Contract 75D30124D19082
Award Date 7/1/24
Last Date to Order 6/30/25
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Pfizer Inc., a large pharmaceutical manufacturer. The $102,613,000 contract is for the delivery of 13 standard adult vaccines, including hepatitis, pneumococcal, tetanus, herpes zoster, measles/mumps/rubella, meningococcal, human papillomavirus, and varicella vaccines. Vaccines must have a minimum 12-month shelf life and be delivered within 15 business days...
- The Centers for Disease Control and Prevention (CDC) has awarded Pfizer Inc. an Indefinite Delivery Contract (IDC) for the supply of various adult vaccines to support immunization programs under Section 317(j) of the Public Health Service Act. The $103,060,230.33 contract, which runs from July 1, 2023 to June 30, 2024, covers a range of vaccines including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus and diphtheria toxoids, herpes zoster, measles-mumps-rubella, meningococcal...
- The provided information describes an Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a leading global pharmaceutical corporation. The $425.5 million IDC, with a period of performance running from June 2023 to June 2024, is for the procurement of adult COVID-19 vaccines. As a major supplier of pharmaceutical products and vaccines to the U.S. federal government, Pfizer holds several significant Indefinite Delivery Vehicles (IDVs),...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. to purchase a variety of pediatric vaccines for the Vaccines for Children (VFC) program. The $1.5 billion contract has a period of performance from April 1, 2023 to March 31, 2024. The contract will procure a minimum of 100 doses up to maximum quantities ranging from 100,000 to 13 million doses for 21...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. as the prime contractor. The contract has a ceiling value of $1,517,947,500.00 and a period of performance from April 1, 2022 through March 31, 2023. It is a multiple award contract vehicle that will provide up to 23 standard pediatric vaccines to support CDC's Immunization Awardees and the Vaccines for...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a large pharmaceutical manufacturer, to procure a variety of pediatric vaccines for the Vaccines for Children (VFC) program. The contract has a ceiling value of $1,914,795,500.00 and a period of performance from April 1, 2024 through March 31, 2025. The solicitation sought offers for 27 different pediatric vaccines including vaccines for diseases such as dengue, diphtheria,...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a large pharmaceutical manufacturer, to provide a range of standard pediatric vaccines to support immunization programs under the Vaccines for Children (VFC) program and Section 317(j) of the Public Health Service Act. The $1.6 billion multiple-award IDC has a period of performance from April 1, 2021 through March 31, 2022, with no small business set-asides utilized. The...
- Pfizer Inc. is providing adult vaccines to the Centers for Disease Control and Prevention under a multiple award indefinite delivery contract. The contract was awarded on July 1, 2020 with a potential value of $48.8 million. Pfizer will supply vaccines for hepatitis A & B, pneumococcal disease, tetanus, diphtheria, herpes zoster, pertussis, measles, mumps, rubella, meningitis, human papillomavirus, varicella, and serogroup B meningococcal disease. Delivery will support immunization...
- The federal contract IDV award is for the delivery of adult vaccines to the Centers for Disease Control and Prevention (CDC). The prime contractor is Pfizer Inc., a global pharmaceutical corporation headquartered in New York. The contract has a total ceiling value of $117,849,500.00 and a period of performance from July 1, 2025, through June 30, 2026. This multiple-award IDV contract is not set aside for any specific business size or type. Pfizer, as a large manufacturer of goods, will provide a...
- This federal Indefinite Delivery Contract (IDC) award to Pfizer Inc. is for the procurement of COVID-19 adult vaccines on behalf of the Centers for Disease Control and Prevention (CDC). The multiple-award contract has a total ceiling value of $498,550,000 and a period of performance through September 30, 2025. As the prime contractor, Pfizer will be responsible for delivering a range of pharmaceutical products to support federal healthcare programs, including the Vaccines for Children (VFC)...